NIH head fields grant questions

NIH is nearing the end of a linkurl:review;http://www.the-scientist.com/article/display/53412/ of the peer review facet of their granting process, and this Friday (Dec. 7) NIH director Elias Zerhouni will linkurl:meet;http://www.the-scientist.com/blog/display/53750/ with his Advisory Committee to the Director to discuss, among other things, the NIH grant peer review process. This afternoon (Dec. 4), Zerhouni took the discussion to the internet in a live chat session with researchers across the

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
NIH is nearing the end of a linkurl:review;http://www.the-scientist.com/article/display/53412/ of the peer review facet of their granting process, and this Friday (Dec. 7) NIH director Elias Zerhouni will linkurl:meet;http://www.the-scientist.com/blog/display/53750/ with his Advisory Committee to the Director to discuss, among other things, the NIH grant peer review process. This afternoon (Dec. 4), Zerhouni took the discussion to the internet in a live chat session with researchers across the nation, hosted on the __The Chronicle of Higher Education__'s linkurl:website.;http://chronicle.com/live/2007/12/zerhouni/chat.php3 The first question Zerhouni tackled was from James O'Rourke of the University of Connecticut Health Center, who asked: "Why cannot more grants for smaller amounts be awarded for innovative start-up projects, to keep alive ideas that need time to show promise?" Zerhouni responded, writing, "We are indeed making more linkurl:grants;http://www.the-scientist.com/blog/display/53456/ for Innovative projects and to keep alive ideas that need time," citing the fact that about 470 scientists were funded by New Innovator Awards, NIH Director Bridge Awards, and Pathway to Independence grants this year. Tim Leshan of Brown University asked Zerhouni about the fate of young researchers seeking NIH support. According to NIH data, only 15 percent of applicants under age 40 received NIH grants in 2006. "What can be done to ensure we don't lose a whole generation of scientists?" wrote Leshan. "We have set a goal of no less than 1523 new investigators to be funded per year which [is] the average of the past five years and we achieved 1608 in 2007," Zerhouni responded. "We need to continue to encourage our early career scientists across the board and we are doing so within the budgetary constraints we have." Later in the discussion, Simo Arredouani of Harvard University returned to the topic of NIH's treatment of young investigators, this time asking the director about postdocs. "How can a postdoc live on $30K/year in a city like Boston for example?" Arredouani asked. "Is there a will at NIH to stop this abuse?" "NIH has increased post docs salaries in the past five years and publishes them as guidelines for institutions," Zerhouni wrote, urging Arredouani to visit the NIH linkurl:website;http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-057.html where, a starting postdoc salary for 2007 is listed as $36,996. Some questioners probed Zerhouni on the integrity of the peer review itself. Faith Davis of the Ordway Research Institute in Albany, New York, asked, "Why do reviewers not research some of the material they are asked to judge?" suggesting that some reviewers have built-in biases or are not knowledgeable in the materials they review. Zerhouni replied that Davis' comments were some of the most common received by the agency. He then asked her to "stay tuned" as the NIH attempts to improve its granting process.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours